Form 4 for INGN Inogen Inc
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0000950170-25-032642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-03-04 | 2025-03-03 | INGN | Bourque Michael J. | EVP, CFO, Treas | P - Purchase | $8.32 | +3,000 | 47.6K | +7% | +$25.0K |
| DMT | 2025-03-04 | 2025-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | A - Grant | $0.1036 | +48.2K | 600 | New | +$4,998 |
| DMT | 2025-03-04 | 2025-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | F - Tax | $8.33 | -28.6K | 44.6K | -39% | -$238.1K |
| DT | 2025-03-04 | 2025-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | M - OptEx | $0.00 | +25.0K | 25.6K | +4,167% | $0 |
| DT | 2025-03-04 | 2025-03-01 | INGN | Bourque Michael J. | EVP, CFO, Treas | M - OptEx | $0.00 | -25.0K | 50.0K | -33% | $0 |
| DT | 2025-03-04 | 2025-02-28 | INGN | Bourque Michael J. | EVP, CFO, Treas | A - Grant | $0.00 | +51.0K | 51.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | P | A | 3,000 | $8.32 | 47,646 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-01 | A | A | 47,625 | $0.00 | 63,387 | D | — | — | (F3) The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024. |
| 3 | Common | Common Stock | 2025-03-01 | F | D | 9,838 | $8.33 | 15,762 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025. |
| 4 | Common | Common Stock | 2025-03-01 | M | A | 25,000 | $0.00 | 25,600 | D | — | — | |
| 5 | Common | Common Stock | 2025-03-01 | A | A | 600 | $8.33 | 600 | D | — | — | (F1) Shares acquired through the Company's 2014 Employee Stock Purchase Plan. |
| 6 | Common | Common Stock | 2025-03-01 | F | D | 18,741 | $8.33 | 44,646 | D | — | — | (F4) The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2025. |
| 7 | Derivative | Restricted Stock Unit | 2025-03-01 | M | D | 25,000 | $0.00 | 50,000 | D | — · — to — | 25,000 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F7) 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-28 | A | A | 51,020 | $0.00 | 51,020 | D | — · — to — | 51,020 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F6) Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. |